Concurrently with the launch of the unique liquid toxin Alluzience in Cyprus, GJK Healthpharma Services Ltd proudly hosted a scientific conference at the Hilton hotel on the 18th of November 2023. Driven by our unwavering dedication to providing top-tier training to physicians, the highly-anticipated event proved to be an astounding success. A crowd of over 100 prominent medical professionals, gained invaluable insights from two esteemed speakers, plastic surgeons Prof. Joanna Czuwara & Dr. Magda Korwin from Poland, who shed light on the new era of liquid neurotoxin.
An optimised formulation designed to be liquid from inception to injection
An innovative and ready-to-use neuromodulator
No human- or animal-derived excipients
Engineered for precision and performance
Rapid results within 24 hours
Long-lasting improvements maintained for up to 6 months
Reproducible results over multiple treatment cycles
Well-tolerated safety profile based on clinical data
A safety profile demonstrated in clinical trials
Supported by over 10 years of extensive aboBoNT-A clinical experience
Proven ‘feel-good’ neuromodulator
Provides significant improvements in patient happiness and confidence
Proven treatment satisfaction in 85% of patients at 1 month
